Rasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature B-NHL: A Children's Oncology Group Report

British Journal of Haematology

Volumn 163, Issue 3, 2013, Pages 365-372

  Galardy, Paul J ^a   Hochberg, Jessica ^b   Perkins, Sherrie L ^c   Harrison, Lauren ^b   Goldman, Stanton ^d   Cairo, Mitchell S ^b  

^a MAYO CLINIC   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d Medical City Children's Hospital   (United States)

Author keywords

Burkitt lymphoma; Diffuse large B cell lymphoma; Paediatric; Rasburicase; Tumour lysis syndrome

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; HYDROCORTISONE; LACTATE DEHYDROGENASE; METHOTREXATE; PREDNISONE; RASBURICASE; URIC ACID; VINCRISTINE;

ADOLESCENT; ADULT; ADVANCED CANCER; ANOREXIA; ARTICLE; B CELL LYMPHOMA; CANCER STAGING; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GLOMERULUS FILTRATION RATE; HEADACHE; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NAUSEA; ONSET AGE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; TUMOR LYSIS SYNDROME; URIC ACID BLOOD LEVEL; VOMITING;

BURKITT LYMPHOMA; DIFFUSE LARGE B-CELL LYMPHOMA; PAEDIATRIC; RASBURICASE; TUMOUR LYSIS SYNDROME;

ACUTE KIDNEY INJURY; ADOLESCENT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; CYTARABINE; FEMALE; HUMANS; HYDROCORTISONE; HYPERURICEMIA; INFANT; L-LACTATE DEHYDROGENASE; LYMPHOMA, B-CELL; LYMPHOMA, NON-HODGKIN; MALE; METHOTREXATE; NEOPLASM PROTEINS; PILOT PROJECTS; PREDNISONE; PROSPECTIVE STUDIES; TUMOR LYSIS SYNDROME; URATE OXIDASE; VINCRISTINE; YOUNG ADULT;

EID: 84885401488     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12542     Document Type: Article

References (20)

1. Bowman, W.P., Shuster, J.J., Cook, B., Griffin, T., Behm, F., Pullen, J., Link, M., Head, D., Carroll, A., Berard, C. & Murphy, S. (1996) Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study. Journal of Clinical Oncology, 14, 1252-1261.
2. Cairo, M.S. & Bishop, M. (2004) Tumour lysis syndrome: new therapeutic strategies and classification. British Journal of Haematology, 127, 3-11.
3. Cairo, M.S., Gerrard, M., Sposto, R., Auperin, A., Pinkerton, C.R., Michon, J., Weston, C., Perkins, S.L., Raphael, M., McCarthy, K. & Patte, C. (2007) Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents. Blood, 109, 2736-2743.
4. Cairo, M.S., Lynch, J., Harrison, L., Perkins, S., Shiramizu, B., Gross, T.G., Sanger, W.G. & Goldman, S. (2010a) Safety, kinetics and outcome following rituximab (R) in combination with FAB chemotherapy in children and adolescents (C+A) with stage III/IV (Group B) and BM+/CNS+ (Group C) mature B-NHL: a Children's Oncology Group Report. Journal of Clinical Oncology, 28, 9545.
5. Cairo, M.S., Coiffier, B., Reiter, A. & Younes, A. (2010b) Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. British Journal of Haematology, 149, 578-586.
6. Coiffier, B., Altman, A., Pui, C.H., Younes, A. & Cairo, M.S. (2008) Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. Journal of Clinical Oncology, 26, 2767-2778.
7. Goldman, S.C., Holcenberg, J.S., Finklestein, J.Z., Hutchinson, R., Kreissman, S., Johnson, F.L., Tou, C., Harvey, E., Morris, E. & Cairo, M.S. (2001) A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood, 97, 2998-3003.
8. Goldman, S., Smith, L., Anderson, J.R., Perkins, S., Harrison, L., Geyer, M.B., Gross, T.G., Weinstein, H., Bergeron, S., Shiramizu, B., Sanger, W., Barth, M., Zhi, J. & Cairo, M.S. (2013) Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: a Children's Oncology Group report. Leukemia, 27, 1174-1177.
9. Hande, K.R. & Garrow, G.C. (1993) Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma. American Journal of Medicine, 94, 133-139.
10. Hochberg, J. & Cairo, M. (2008) Tumor lysis syndrome: current perspectives. Haematologica, 93, 9-13.
11. Jeha, S. (2001) Tumor lysis syndrome. Seminars in Hematology, 38, 4-8.
12. Miles, R.R., Arnold, S. & Cairo, M.S. (2012) Risk factors and treatment of childhood and adolescent Burkitt lymphoma/leukaemia. British Journal of Haematology, 156, 730-743.
13. Murphy, S.B. (1980) Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults. Seminars in Oncology, 7, 332-339.
14. Patte, C., Auperin, A., Gerrard, M., Michon, J., Pinkerton, R., Sposto, R., Weston, C., Raphael, M., Perkins, S.L., McCarthy, K. & Cairo, M.S. (2007) Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood, 109, 2773-2780.
15. Pui, C.H., Relling, M.V., Lascombes, F., Harrison, P.L., Struxiano, A., Mondesir, J.M., Ribeiro, R.C., Sandlund, J.T., Rivera, G.K., Evans, W.E. & Mahmoud, H.H. (1997) Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies. Leukemia, 11, 1813-1816.
16. Pui, C.-H., Mahmoud, H.H., Wiley, J.M., Woods, G.M., Leveger, G., Camitta, B., Hstings, C., Blaney, S.M., Relling, M.V. & Reaman, G.H. (2001) Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphoma. Journal of Clinical Oncology, 19, 697-704.
17. Schwartz, G.J., Brion, L.P. & Spitzer, A. (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatric Clinics of North America, 34, 571-590.
18. Seidemann, K., Meyer, U., Jansen, P., Yakisan, E., Rieske, K., Fuhrer, M., Kremens, B., Schrappe, M. & Reiter, A. (1998) Impaired renal function and tumor lysis syndrome in pediatric patients with non-Hodgkin's lymphoma and B-ALL. Observations from the BFM-trials. Klinische Padiatrie, 210, 279-284.
19. Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J. & Vardiman, J.W. (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon.
20. Wossmann, W., Schrappe, M., Meyer, U., Zimmermann, M. & Reiter, A. (2003) Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/leukemia before and after introduction of prophylactic use of urate oxidase. Annals of Hematology, 82, 160-165.